Stay updated with our new products and services. You can unsubscribe at any time.
BRD4 Targeted Library
Epigenetic regulators are new popular targets for cancer treatment. One of the promising epigenetic drug targets is Bromodomain-containing Protein 4 (BRD4) that binds to acetylatedhistone lysine residues and stimulates transcriptional elongation leading to expression of growth-promoting genes.
This protein is evaluated as therapeutic target in myeloid leukemia and several BRD4 inhibitors have shown to be effective against leukemia.
We offer new receptor-based BRD4 Inhibitors Targeted Library (401 compounds) based on OTAVAchemicals Drug-like Green Collection. The library has been designed with docking of each compound in binding site of BRD4 X-ray crystal structure (PDB ID: 4J0S). This recently published complex of BRD4 with inhibitor has high resolution 1.84 Å and provides an excellent basis for focused library preparation.
The compounds have been selected by energy score, presence of hydrogen bond with side chain of Asn140 (this H-bond is present in many complexes BRD4 with inhibitor) and visual inspection for favorable ligand position in binding site. The library comprises drug-like compounds only.
All compounds are in stock, cherry-picking is available.
The library (DB, SD, XLS, PDF format) as well as the price-list is available on request. Feel free to contact us or use on-line form below to send an inquiry if you are interested to obtain this library or if you need more information.